Understanding the Average Age of Skin Cancer Diagnosis: Facts and Statistics

Skin cancer is a prevalent health concern, recognized as the most common cancer both in the United States and globally. It’s critical to understand the facts surrounding this disease, especially concerning the Average Age Of Skin Cancer Diagnosis, to promote early detection and prevention. This article delves into essential skin cancer statistics, providing a comprehensive overview to enhance your awareness and encourage proactive health measures.

Key Skin Cancer Facts

Skin cancer’s widespread impact is underscored by several alarming statistics:

1 in 5 Americans will be diagnosed with skin cancer before turning 70.
Tragically, more than 2 individuals in the U.S. succumb to skin cancer every hour.
Experiencing 5 or more sunburns significantly elevates the risk of melanoma, doubling your chances of developing this severe form of skin cancer.
Early detection is a game-changer; when melanoma is caught in its initial stages, the 5-year survival rate dramatically increases to 99 percent.

These facts highlight the urgency of understanding skin cancer risks and adopting preventive strategies.

General Skin Cancer Statistics

The sheer scale of skin cancer diagnoses in the United States is staggering:

Over 9,500 people receive a skin cancer diagnosis daily in the U.S. This high incidence rate contributes to more than two deaths every hour from the disease.
Nonmelanoma skin cancers are incredibly common, with over 5.4 million cases treated in approximately 3.3 million people in the U.S. in 2012. These figures are still considered the most reliable estimates to date.
The frequency of skin cancer surpasses all other cancers combined in the U.S. each year, emphasizing its status as a leading cancer type.
By the age of 70, at least one in five Americans will have been diagnosed with skin cancer, illustrating the lifetime risk many face.
Actinic keratosis, a precancerous condition, affects more than 58 million Americans, highlighting a significant population at risk of developing skin cancer.
The economic burden of skin cancer is substantial, with annual treatment costs in the U.S. estimated at $8.1 billion. This includes approximately $4.8 billion for nonmelanoma and $3.3 billion for melanoma skin cancers.

These statistics underscore the importance of public health initiatives aimed at skin cancer prevention and early detection.

Nonmelanoma Skin Cancer: Age and Risk

Nonmelanoma skin cancers, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are strongly linked to cumulative sun exposure over a lifetime. While the average age of diagnosis for nonmelanoma skin cancers tends to be later in life, the damage begins much earlier.

There was a significant 77 percent increase in nonmelanoma skin cancer diagnoses and treatments in the U.S. between 1994 and 2014, pointing to rising incidence rates.
UV radiation from the sun is the primary culprit, responsible for about 90 percent of nonmelanoma skin cancers.
Basal cell carcinoma (BCC) is the most frequently diagnosed skin cancer, with an estimated 3.6 million new cases each year in the U.S.
Squamous cell carcinoma (SCC) follows as the second most common, with around 1.8 million cases diagnosed annually in the U.S.
Globally, over 5,400 people die from nonmelanoma skin cancer every month, demonstrating its serious global impact.
Organ transplant recipients face a significantly heightened risk, being approximately 100 times more likely to develop squamous cell carcinoma compared to the general population.
Consistent use of sunscreen with SPF 15 or higher can dramatically reduce risk, with one study indicating about a 40 percent reduction in the development of squamous cell carcinoma when used as directed.
Merkel cell carcinoma, a less common but aggressive type, sees about 3,000 new cases each year in the U.S., with a recurrence rate of approximately 40 percent.

Melanoma: Age and Severity

Melanoma, while less common than nonmelanoma skin cancers, is far more aggressive and potentially deadly. Understanding the average age of melanoma diagnosis and its risk factors is crucial for timely intervention.

Projections indicate a continued rise in melanoma cases, with an estimated 5.9 percent increase in new diagnoses by 2025.
Melanoma deaths are also expected to increase, with a projected 1.7 percent rise in 2025.
In 2025, it’s estimated that 212,200 melanoma cases will be diagnosed in the U.S., with approximately half being invasive.
Invasive melanoma cases have surged in recent years, with a 42 percent increase in annual diagnoses in the decade between 2015 and 2025.
Melanoma is projected to cause 8,430 deaths in 2025, highlighting its severity.
Sun exposure is a major cause, with a UK study attributing about 86 percent of melanomas to UV radiation from the sun.
Timely treatment is critical for melanoma survival. Delays in treatment after biopsy can significantly worsen outcomes.
Survival rates for melanoma are heavily dependent on the stage at diagnosis. The five-year survival rate is over 99 percent for early detection but drops significantly as the disease progresses.
A significant portion of melanomas, 70 to 80 percent, arise on seemingly normal skin, not from pre-existing moles.
Experiencing more than five sunburns doubles an individual’s risk of melanoma, emphasizing the importance of sun protection from a young age.
Regular sunscreen use can reduce melanoma risk by 50 percent.
Melanoma accounts for a notable percentage of new cancer cases, especially in younger individuals.
Men under 49 are at a higher risk of developing melanoma than any other cancer except for colon and rectum cancers.
Men aged 15 to 39 are significantly more likely to die from melanoma compared to women in the same age group.
Women under 49 are more prone to melanoma than any other cancer except breast and thyroid cancers.
After age 50, melanoma incidence becomes higher in men than women. However, before 49, non-Hispanic white women have a higher incidence rate than white men.

Indoor Tanning and Younger Age of Diagnosis

Indoor tanning is a significant risk factor, particularly contributing to skin cancer diagnoses at a younger age.

UV radiation from indoor tanning is a proven carcinogen.
The World Health Organization classifies UV tanning devices in its highest risk category for cancer-causing agents, alongside substances like plutonium and cigarettes.
Indoor tanning devices can emit UV radiation 10 to 15 times stronger than the midday sun.
Many states have banned or restricted indoor tanning for minors due to its proven risks.
Some countries, like Australia and Brazil, have completely banned indoor tanning.
The economic cost of treating skin cancers linked to indoor tanning is substantial, costing $343.1 million annually in the U.S.
Hundreds of thousands of skin cancer cases each year are linked to indoor tanning, including melanomas.
The risk of skin cancer from indoor tanning is higher than the risk of lung cancer from smoking, highlighting its extreme danger.
Indoor tanning history significantly increases the risk of both squamous and basal cell carcinomas.
Starting indoor tanning before age 35 increases melanoma risk by 75 percent.
Indoor tanning is particularly dangerous for young women, who are significantly more likely to be diagnosed with melanoma in their 20s if they have tanned indoors.
Studies show a very high percentage of young women diagnosed with melanoma have a history of tanning bed use.
While indoor tanning among high school students has decreased, it remains a concern.

Skin Aging and Cumulative Sun Exposure Over Age

Sun damage accumulates over time, increasing skin cancer risk as we age.

Approximately 80 percent of visible skin aging in Caucasian women is attributed to sun exposure.
Daily sunscreen use significantly reduces signs of skin aging compared to non-users.
Lifetime sun exposure is cumulative, with a significant portion occurring before adulthood, but continuing to accumulate throughout life.

Ages	Average Accumulated Sun Exposure*
1-18	23 percent
19-40	47 percent
41-59	74 percent
60-78	100 percent
*Based on a 78-year life span

Ethnicity and Disparities in Age and Stage at Diagnosis

Ethnicity plays a role in skin cancer risk and outcomes, including the stage at diagnosis and survival rates, which can be linked to age of detection and access to care.

Melanoma survival rates are significantly lower for Black patients compared to white patients, highlighting disparities in outcomes.
Skin cancer represents varying percentages of all cancers in different ethnic groups, with lower proportions in Asian and Black populations compared to Hispanic populations.
Melanomas in people of color often occur in less sun-exposed areas, leading to potential delays in diagnosis and contributing to later stage diagnoses at potentially younger ages.
In nonwhite individuals, the foot is a common site for skin cancer, often affected in a significant percentage of cases.
Squamous cell carcinoma is the most common skin cancer in Black people.
Late-stage melanoma diagnoses are more common among Hispanic and Black people compared to non-Hispanic white people, potentially impacting average age of diagnosis for advanced stages.
Acral lentiginous melanoma (ALM) is more frequent in people of color, while superficial spreading melanoma is more common in Caucasian and Hispanic populations.

Pediatric Skin Cancer: Diagnosis in Younger Age Groups

While less common, skin cancer does occur in children and adolescents, and understanding its characteristics in younger age groups is important.

Melanoma in children and adolescents is rare, accounting for a small percentage of new melanoma cases.
In pediatric cancers overall, melanoma represents a small percentage.
Diagnosis of childhood melanoma is often delayed due to misdiagnosis, occurring in a significant percentage of cases.

Conclusion: Promoting Early Detection at Every Age

While there isn’t a single “average age of skin cancer diagnosis” that applies uniformly across all types and populations, the data clearly indicates that skin cancer risk is a lifelong concern. Cumulative sun exposure from youth onwards significantly contributes to the development of both nonmelanoma and melanoma skin cancers later in life. Indoor tanning drastically increases risk, especially for younger individuals, leading to diagnoses at younger ages. Furthermore, disparities exist across ethnicities, affecting both risk and stage at diagnosis.

Understanding these facts underscores the importance of year-round sun safety, avoiding indoor tanning, and performing regular self-skin exams at all ages. Early detection remains the most powerful tool in improving outcomes for skin cancer. Consulting with a dermatologist for regular skin checks, especially if you have risk factors, is a crucial step in proactive skin health management, regardless of your age.

References

Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol 2015; 151(10):1081-1086.
Cancer Facts and Figures 2025. American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2025/2025-cancer-facts-and-figures-acs.pdf Accessed January 21, 2025.
Stern, RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 2010; 146(3):279-282.
The Lewin Group, Inc. The Burden of Skin Diseases 2005. Prepared for the Society for Investigative Dermatology, Cleveland, OH, and the American Academy of Dermatology Assn., Washington, DC, 2005.
Guy GP, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med 2015; 48(2):183-187. doi: 10.1016/j.amepre.2014.08.036.
Mohan SV, Chang AL. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep 2014; 3(1):40-45. doi:10.1007/s13671-014-0069-y.
Koh HK, Geller AC, Miller DR, et al. Prevention and early detection strategies for melanoma and skin cancer: Current status. Arch Dermatol 1996; 132(4):436-442.
Our New Approach to a Challenging Skin Cancer Statistic. The Skin Cancer Foundation. https://www.skincancer.org/blog/our-new-approach-to-a-challenging-skin-cancer-statistic/. Accessed January 20, 2024.
Mansouri B, Housewright C. The treatment of actinic keratosesâ€”the rule rather than the exception. J Am Acad Dermatol 2017; 153(11):1200. doi:10.1001/jamadermatol.2017.3395.
LindelÃ¶f B, Sigurgeirsson B, GÃ¤bel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143(3):513-9.
Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. The Lancet 1999; 354(9180):723-729.
Parkin DM, Mesher D, Sasieni P. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010. Br J Cancer 2011; 105:S66-S69.
Conic RZ, Cabrera CI, Khorana AA, Gastman BR. Determination of the impact of melanoma surgical timing on survival using the National Cancer Database. J Am Acad Dermatol 2018; 78(1):40-46.e7. doi:10.1016/j.jaad.2017.08.039.
Cymerman RM, Shao Y, Wang K, et al. De novo versus nevus-associated melanomas: Differences in associations with prognostic indicators and survival. J Natl Cancer Inst 2016 May 27; 108(10). doi:10.1093/jnci/djw121.
Pfahlberg A, KÃ¶lmel KF, Gefeller O. Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation-induced melanoma. Br J Dermatol 2001; 144:3:471-475.
Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011; 29(3):257-263.
Fisher DE, Geller AC. Disproportionate burden of melanoma mortality in young US men. JAMA Dermatol 2013; 149(8): 903. doi:10.1001/jamadermatol.20134437.
Ultraviolet-radiation-related exposures. Broad-spectrum UVR, pp. 1-5. NTP (National Toxicology Program). 2014. Report on Carcinogens, Thirteenth Edition. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service. http://ntp.niehs.nih.gov/ntp/roc/content/profiles/ultravioletradiationrelatedexposures.pdf. Accessed January 26, 2018.
El Ghissassi F, Baan R, Straif K, et al. Special report: policy. A review of human carcinogensâ€”part D: radiation. The Lancet 2009; 10(8):751-752. doi: https://doi.org/10.1016/S1470-2045(09)70213-X.
Tanning Lamps, Booths and Beds. Food and Drug Administration. https://www.fda.gov/radiation-emitting-products/tanning/tanning-products. Accessed January 30,2024.
Indoor tanning restrictions for minors. AIM at Melanoma. https://www.aimatmelanoma.org/legislation-policy-advocacy/indoor-tanning/. Accessed January 30,2024.
Mathes S, Lindwedel KS, Nilsen LT, Kaiser I, Pfahlberg AB, Gefeller O. Global Tanning Bed Advertising: A Comparison of Legal Regulations on Three Continents. Cancers (Basel). 2023;15(17):4362. Published 2023 Sep 1. doi: 3390/cancers15174362
Waters HR, Adamson A. The health and economic implications of the use of tanning devices. J Cancer Policy 2017; http://dx.doi.org/10.1016/j.jcpo.2016.12.003.
Wehner MR, Chren MM, Nameth D, et al. International prevalence of indoor tanning: a systematic review and meta-analysis. JAMA Dermatol 2014; 150(4):390-400. doi:10.1001/jamadermatol.2013.6896.
Ferrucci LM, Cartmel B, Molinaro AM, et al. Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol 2012 Oct; 67(4):552-62. doi:10.1016/j.jaad.2011.11.940.
Lazovich D, Vogel RI, Weinstock MA, et al. Association between indoor tanning and melanoma in younger men and women. JAMA Dermatol 2016; 152(3): 268â€“275. doi:10.1001/jamadermatol.2015.2938
Global Burden of Disease Cancer Collaboration. Global, regional and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017. JAMA Oncol. 2019;5(12):1749-1768. doi:10.1001/jamaoncol.2019.2996.
The International Agency for Research on Cancer Working Group. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Canc 2006; 120:1116-1122.
Guy GP Jr, Berkowitz Z, Everett Jones S, et al. Prevalence of indoor tanning and association with sunburn among youth in the United States. JAMA Dermatol 2017; 153(5):387-390. doi:10.1001/jamadermatol.2016.6273.
Flament F, Bazin R, Laquieze S, Rubert V, Simonpietri E, Piot B. Effect of the sun on visible clinical signs of aging in Caucasian skin. Clin Cosmet Investig Dermatol. 2013;6:221-232. Published 2013 Sep 27. doi:10.2147/CCID.S44686Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med 2013; 158(11):781-790.
Godar DE, Urbach F, Gasparro FP, van der Leun JC. UV doses of young adults. Photochem Photobiol 2003; 77(4):453-7.
Gloster HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006; 55:741-60.
Hu S, Soza-Vento RM, Parker DF, et al. Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida. Arch Dermatol 2006; 142(6):704-8.
Bradford, Porcia T. Skin Cancer in Skin of Color. Dermatol Nurs 2009 Jul-Aug; 21(4): 170-178.
Childhood Melanoma Treatment (PDQ) â€“ Health Professional Version. National Cancer Institute. https://www.cancer.gov/types/skin/hp/child-melanoma-treatment-pdq. Accessed January 30, 2024.
Han D, Zager JS, Han G, et al. The unique clinical characteristics of melanoma diagnosed in children. Ann Surg Oncol. 2012;19(12):3888â€“3895. doi:10.1245/s10434-012-2554-5
Paulson KG, Gupta D, Kim TS, et al. Age-specific incidence of melanoma in the United States. JAMA Dermatol. 2020; 156(1):57â€“64. doi:10.1001/jamadermatol.2019.3353
Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics 2005; 115(3):649-57.
Cancer Facts and Figures 2015. American Cancer Society. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2015.html. Accessed January 21, 2025.
Le Clair MZ, Cockburn MG. Tanning bed use and melanoma: Establishing risk and improving prevention interventions. Prev Med Rep. 2016; 3:139â€“144. Published 2016 Jan 14. doi: 10.1016/j.pmedr.2015.11.016
McEvoy AM, Lachance K, Hippe DS, et al. Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis. JAMA Dermatol. 2022;158(4):382-389. doi:10.1001/jamadermatol.2021.6096
Cancer Facts and Figures 2024. American Cancer Society. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2024-cancer-facts-figures.html Accessed January 21, 2025.

Last updated: February 2024